Skip to main content
Caplight Logo









Alpheus Medical

Alpheus Medical

Private
Chanhassen, MinnesotaHealthcare & Life Scienceshttps://alpheusmedical.com/

Last Round

Series B

Jul 30, 2026

Total Funding Raised

$82M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Alpheus Medical is a biotechnology company developing a sonodynamic therapy (SDT) platform that pairs a tumor-accumulating drug with low-intensity ultrasound to treat solid body cancers.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medical devicesonodynamic therapysolid tumor treatmentglioblastoma treatmentnon-invasive surgerylow-intensity ultrasoundbiotechnologyclinical trialsneuro-oncologymedtechcancer therapydrug-device combinationtherapeutic platformoutpatient therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alpheus Medical Comparables

Compare Alpheus Medical with similar companies based on industry and business-model similarity.

Alpheus Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QV Bioelectronics
80%
Hemerion Therapeutics
78%
SonALAsense
78%

Alpheus Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 30, 2026
Series BMay 15, 2025
Series A ExtensionNov 10, 2022
Series ANov 17, 2021

Key People

Founding team and executive leadership

Imran Eba

Chief Financial Officer

Executive Team

Alpheus Medical Investors

Notable investors and investment history

Alpheus Medical investors
InvestorRounds
Action Potential Venture CapitalSeries A Extension, Series B, Series A
OrbiMedSeries A Extension, Series B, Series A
The Sontag FoundationSeries B
BrightEdgeSeries A, Series A Extension, Series B
Samsara BioCapitalSeries B
HealthQuest CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 30, 2026

    $60M round completed.

  • May 17, 2026

    Monthly visitors increased 83% MoM.

Alpheus Medical Filings

Explore SEC and related filing metadata, where available.

Alpheus Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Alpheus Medical's valuation, stock price, and market status.

Is Alpheus Medical a public or private company?

Alpheus Medical is a private company.

What is the current stock price of Alpheus Medical?

Alpheus Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Alpheus Medical worth (valuation)?

Valuation information for Alpheus Medical is not publicly available.

Can I buy Alpheus Medical stock?

Alpheus Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Alpheus Medical's last funding round?

Alpheus Medical's most recent funding round was Series B on May 15, 2025.

Who are the main investors in Alpheus Medical?

Key investors in Alpheus Medical include Samsara BioCapital, HealthQuest Capital.

Will Alpheus Medical IPO soon?

No public IPO plans have been announced for Alpheus Medical.

How can I track Alpheus Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alpheus Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChanhassen, Minnesota
Employee Range9
Year Founded2018
Last FundingJul 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?